Numerous people throughout the UK are experiencing a mysterious and debilitating dermatological condition that has stumped doctors. Sufferers describe their skin as becoming badly inflamed, cracked and flaking, commonly affecting large areas of their body, yet many doctors have trouble diagnosing or treating the condition. The condition, called topical steroid withdrawal (TSW) or red skin syndrome, has generated significant attention on social media, with videos documenting patients’ experiences accumulating over one billion views on TikTok alone. Although it affects a growing number of people, TSW is so little understood that some GPs and skin specialists query whether it actually exists at all. Now, in a first-of-its-kind move, researchers in the UK are launching a significant research project to investigate what is responsible for these unexplained symptoms and how some people come to develop the condition while others remain unaffected.
The Unexplained Illness Sweeping Across the UK
Bethany Gamble’s experience exemplifies the profound effects of topical steroid withdrawal on those affected. The 21-year-old from Birmingham had handled her eczema successfully with steroid creams since childhood, but at eighteen, her condition worsened considerably. Her skin became intensely inflamed and red, cracking and oozing whilst the itching became what she characterises as “bone deep”. Within two years, the pain had become so intense that she was stuck in her bed, requiring round-the-clock care from her mother. Most concerning, Bethany found herself repeatedly dismissed by doctors who attributed her symptoms to standard eczema and continued prescribing the very treatments she thought were responsible for her suffering.
The medical community is split on how to address TSW, with significant discord about its basic nature. Some experts view it as a serious allergic reaction to the steroid creams that represent the standard treatment for eczema across the NHS. Others contend it represents a serious exacerbation of pre-existing skin conditions rather than a unique syndrome, whilst a handful are sceptical of its existence. This clinical uncertainty has left patients like Bethany caught in a diagnostic limbo, finding it hard to obtain proper treatment. The absence of agreement has encouraged Professor Sara Brown at the University of Edinburgh to set up the first major UK research project studying TSW, funded by the National Eczema Society.
- Symptoms include significant swelling, cracking skin and persistent pruritus throughout the body
- Patients document “elephant skin” hardening and excessive flaking of dead skin cells
- Healthcare practitioners frequently overlook TSW as standard eczema or decline to recognise it
- The condition can be so debilitating that sufferers find themselves unable to perform daily activities
Living with Steroid Topical Withdrawal
From Mild Eczema to Disabling Symptoms
For many sufferers, topical steroid withdrawal represents a severe decline from a formerly stable dermatological condition. What begins as intermittent itching in skin creases can quickly progress into a full-body inflammatory response that renders patients incapable of functioning. The change typically happens abruptly, without warning, converting a manageable chronic condition into an severe medical emergency. People describe their skin becoming impossibly hot, red and inflamed, with severe cracking and weeping that demands constant attention. The physical toll is worsened by fatigue, as the persistent itching prevents sleep and recovery, establishing a vicious cycle of deterioration.
The pace at which TSW progresses catches many sufferers off guard. Those who have lived with eczema for years, sometimes decades, are unprepared for the intensity of symptoms that develop when their condition rapidly deteriorates. Routine activities become monumental challenges: showering becomes excruciating, dressing demands help, and preserving hygiene demands substantial energy. Some patients recount feeling as though their skin is being attacked from within, with inflammation moving through their body in patterns that bear little resemblance to their past episodes. This dramatic transformation often leads sufferers to obtain emergency care, only to encounter doubt from healthcare professionals.
The Push for Recognition
Perhaps the most distressing aspect of topical steroid withdrawal is the medical gaslighting that frequently accompanies it. Patients experiencing severe, unexplained symptoms are consistently informed they simply have eczema worsening, despite their assertion that this is fundamentally different from anything they’ve experienced before. Doctors frequently react by recommending higher-strength steroids or increased doses, possibly exacerbating the very condition patients believe the creams caused. This cycle of dismissal leaves sufferers feeling abandoned by the medical establishment, forced to navigate their illness alone whilst being told their lived experience is invalid. Many patients report experiencing repeated invalidation, their concerns dismissed as anxiety or psychological rather than genuine physiological symptoms.
The absence of professional agreement has established a significant divide between what patients report and clinical acknowledgement. Without established diagnostic standards or defined treatment approaches, general practitioners and skin specialists struggle to identify TSW or provide suitable care. Some practitioners remain completely sceptical the disorder is real, treating all severe presentations as standard eczema or other known dermatological conditions. This professional uncertainty results in delayed diagnosis, inappropriate treatment and significant emotional suffering for patients already suffering physically. The increased prominence of TSW on online platforms has highlighted this diagnostic gap, encouraging investigation to examine the experiences reported by vast numbers of individuals, even as the healthcare profession continues to disagree on the appropriate response.
- Symptoms can emerge abruptly in people with formerly controlled eczema managed by topical steroids
- Patients frequently encounter disbelief from medical practitioners who attribute deterioration to typical eczema exacerbations
- Medical professionals remain divided on whether TSW is a real disorder or severe eczema exacerbation
- Lack of diagnostic criteria means many sufferers find it difficult to obtain suitable care and support
- Online platforms has amplified patient voices, with TSW hashtags reaching more than one billion views globally
Racial Inequities in Assessment and Clinical Management
The diagnostic difficulties surrounding TSW become increasingly evident amongst people with darker skin tones, where symptoms can be considerably more difficult to recognise visually. Erythema and inflammatory responses, the hallmark signs of TSW in lighter-skinned individuals, present distinctly across different ethnic groups, yet many clinical guidelines remain focused on how the condition appears in white patients. This disparity means that individuals from Black, Asian and minority ethnic backgrounds experiencing TSW commonly experience substantially longer periods in identification and acceptance. Medical staff trained primarily on presentations in lighter skin may fail to recognise the typical indicators, resulting in further misdiagnosis and unsuitable therapeutic suggestions that can exacerbate suffering.
Research into TSW has historically overlooked the experiences of people with darker complexions, sustaining a pattern where their symptoms remain under-documented and under-studied. The online discussions shaping TSW discourse have been largely shaped by individuals with lighter complexions, risking distortion of medical understanding and community understanding. As Professor Sara Brown’s pioneering British research advances, guaranteeing inclusive participation amongst participants will be crucial to creating genuinely comprehensive diagnostic criteria and treatment approaches. Without intentional action to prioritise the perspectives of diverse populations, healthcare disparities in TSW identification and care threaten to increase, abandoning at-risk communities without adequate support or answers.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Research and Treatment Options Emerging
First Major UK Study In Progress
Professor Sara Brown’s groundbreaking research at the University of Edinburgh constitutes a significant milestone for TSW sufferers pursuing validation and clarity. Funded by the National Eczema Society, the study has brought together many participants throughout the United Kingdom to explore the underlying mechanisms behind topical steroid withdrawal. By examining symptoms, saliva samples and skin biopsies, researchers aim to identify why certain individuals develop TSW whilst others on identical steroid regimens do not. This rigorous investigation marks a significant shift from dismissal to thorough inquiry.
The investigative group working alongside Dr Alice Burleigh from advocacy group for patients Scratch That, brings both medical knowledge and lived experience to the research. Their collaborative approach accepts that patients themselves hold vital knowledge into their health situations. Professor Brown has noted patterns in TSW that cannot be explained by conventional eczema understanding, including characteristic “elephant skin” thickening, extreme shedding and clearly defined inflammatory patches. The study results could significantly transform how doctors handle diagnosis and care of this serious condition.
Treatment Options and Their Limitations
Presently, treatment options for TSW remain limited and frequently inadequate. Many healthcare professionals persist in prescribing topical steroids despite evidence indicating they could worsen symptoms in those predisposed. Some patients describe short-term improvement from emollients, antihistamines and oral medications, though outcomes differ significantly. Dermatologists are split on most effective management plans, with some recommending full steroid withdrawal whilst others suggest slow reduction. This shortage of unified guidance forces patients to navigate their therapeutic pathways mostly in isolation, drawing substantially on peer support networks and web-based forums for direction.
Psychological support and specialist dermatological care may provide advantages, yet access remains patchy across the NHS. Some patients have explored alternative approaches including changes to diet, environmental controls and whole-person treatment approaches, though scientific evidence supporting these interventions is limited. The absence of established clinical protocols means treatment decisions frequently rely upon individual dermatologist experience and patient preference rather than research-informed standards. Until robust research produces definitive answers, TSW sufferers frequently describe feeling abandoned by conventional medicine.
- Emollients and moisturisers to maintain the skin’s protective barrier and minimise water loss
- Antihistamine medications to control itching and associated sleep disruption in flare episodes
- Systemic corticosteroids or immune-suppressing agents for serious presentations with specialist oversight
- Psychological counselling to address trauma and anxiety related to prolonged skin suffering
Sounds of Optimism and Resolve
Despite the uncertainty regarding TSW and the frequently dismissive attitudes from medical practitioners, patients are finding strength in shared community and collective experience. Online support networks have emerged as lifelines for those battling the condition, providing practical guidance and validation when traditional medicine has let them down. Many sufferers describe the point at which they found the TSW hashtag as transformative—finally connecting with others with identical symptoms and realising they were not alone in their suffering. This unified voice has been powerful enough to spark the first serious research efforts, demonstrating that patient-led campaigns can drive medical progress even when institutional structures stay unconvinced.
Bethany Gamble and people in similar situations are determined to increase visibility and campaign for due recognition of TSW within the medical establishment. Their willingness to share deeply personal accounts of their struggles on social media has encouraged open dialogue around a illness that various medical professionals still decline to recognise. These individuals are not remaining passive for responses; they are taking part in clinical trials, tracking their signs carefully, and insisting that their experiences be taken seriously. Their determination in the confronting ongoing pain and dismissive healthcare practices offers hope that responses might prove to be within grasp, and that upcoming sufferers will be given the validation and care they critically depend upon.
- Patient-led research initiatives are filling gaps overlooked by traditional medical institutions and accelerating understanding of TSW
- Online communities offer psychological assistance, practical coping strategies, and peer validation for isolated sufferers globally
- Advocacy efforts are gradually shifting clinical attitudes, prompting dermatologists to examine rather than overlook individual accounts
